Calcium Gluconate Market (By Grade: Pharmaceutical Grade, Food Grade; By Form: Liquid, Tablet, Powder, Gel; By Function: Calcium Supplement, Bone Health, Antacid, Skincare And Cosmetics; By Application: Pharmaceuticals, Food & Beverages, Nutraceuticals, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global calcium gluconate market size was valued at USD 98.72 billion in 2023 and is anticipated to reach around USD 179.31 billion by 2033, growing at a CAGR of 6.15% from 2024 to 2033. Rising demand for calcium gluconate from various industries, such as F&B, pharmaceutical, and agriculture, is a key factor driving market revenue growth.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. calcium gluconate market size surpassed USD 28.14 billion in 2023 and is expected to be worth around USD 51.78 billion by 2033 at a CAGR of 6.28% from 2024 to 2033.
North America dominated the global calcium glucose market in 2023. This is because calcium gluconate is widely used in pharmaceuticals to treat calcium deficiency, osteoporosis, and other bone-related conditions, driving high demand in the region. Additionally, the availability of various calcium supplements and increasing consumer awareness about health contribute to market growth. With rising disposable income and growing health awareness, the North American market is projected to see the fastest revenue growth during the forecast period.
Asia Pacific is witnessing rapid growth in the calcium gluconate market, driven by increasing consumer demand for healthy products. A significant portion of the population in this region suffers from calcium deficiency, which leads to a greater emphasis on health consciousness and the use of food additives and supplements to address calcium needs.
Countries like China, India, and Japan play key roles in driving industry growth. Despite being the largest milk producer, India faces a notable shortage in calcium intake. This has led to a growing trend of consuming calcium supplements, which has boosted the growth of the calcium gluconate market in the region.
The Europe calcium gluconate market size was calculated at USD 26.65 billion in 2023 and is projected to expand around USD 49.31 billion by 2033, poised to grow at a CAGR of 6.28% from 2024 to 2033.
Year | Market Size (USD Billion) |
2023 | 26.65 |
2024 | 28.82 |
2025 | 30.15 |
2026 | 32.06 |
2027 | 26.65 |
2028 | 36.26 |
2029 | 38.56 |
2030 | 41.00 |
2031 | 43.60 |
2032 | 46.37 |
2033 | 49.31 |
Calcium gluconate is a type of calcium salt derived from gluconic acid. It serves as a calcium supplement and is also used as a key ingredient in pharmaceuticals. You can find it in various forms like powder, liquid, and tablets. This mineral supplement is produced by extracting glycolic acid from lime or calcium carbonate. It's considered unique among essential medicines. Doctors often prescribe calcium gluconate to treat conditions that lead to calcium deficiency, such as hyperparathyroidism-related hypocalcaemia, hypocalcaemia tetany, or deficiency due to rapid growth or pregnancy.
Calcium gluconate, due to its potent nature, restricts its use in many food products, even those fortified with nutrients. In the food industry, calcium gluconate acts as a firming agent in jellies, jams, and fruit preserves, which enhance the texture and stability. It's also added as a nutrient supplement in dairy products, breakfast cereals, and infant formulas. You'll also find it in beverages like bottled water, cold drinks, and juices, as well as in various confectionery items, baked goods, and soy products.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 6.15% |
Global Market Size in 2023 | USD 98.72 Billion |
Global Market Size in 2024 | USD 104.79 Billion |
Global Market Size by 2033 | USD 179.31 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Grade, By Form, By Function, and By Application |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Rising incidence of calcium deficiency
The increasing prevalence of calcium deficiency worldwide is a major factor driving the growth of the calcium gluconate market. It's estimated that over 3.5 million people worldwide are at risk of calcium deficiency. Hypocalcaemia, or low calcium levels, can lead to various medical issues, ranging from mild symptoms to potentially severe or chronic conditions. These factors will significantly contribute to the market share of calcium gluconate. Additionally, the demand for calcium gluconate is also being fueled by the nutraceutical industry. Calcium gluconate serves as a key ingredient in the production of various calcium-based health supplements.
Restraint: Side effects
Excessive intake of calcium gluconate can lead to unpleasant side effects like constipation, decreased appetite, dry mouth, nausea, and vomiting. These effects pose a challenge to the growth of the calcium gluconate market. Also, strict regulations from food authorities limit its usage in food products, which can restrain market growth. Furthermore, the availability of alternative calcium supplements and limited consumer awareness about the benefits of calcium gluconate hinder its market penetration. Consumers may also be cautious due to potential safety concerns related to high-dose calcium supplementation.
Opportunity: Research and development
Research and development efforts are underway to discover new ways to formulate and deliver calcium gluconate, creating the way for innovation. Venturing into emerging markets with improving healthcare infrastructure and higher healthcare spending presents growth opportunities. There's also a focus on developing calcium gluconate supplements with improved bioavailability for better absorption, which greatly benefits the growth of the calcium gluconate market.
Collaboration among healthcare professionals and institutions can help promote the benefits of the calcium gluconate market. Establishing strategic partnerships with pharmaceutical companies to integrate calcium gluconate into their existing product lines is also a key factor in expansion. Investment in marketing campaigns and educational initiatives will raise awareness about calcium gluconate and its various uses. Furthermore, the cosmetic industry shows a rising demand for calcium gluconate, particularly for formulating skincare and haircare products.
The pharmaceutical-grade segment dominated the calcium gluconate market in 2023. Pharmaceutical-grade calcium gluconate is utilized to treat medical conditions such as hyperkalemia, hypercalcemia, etc. Moreover, pharma-grade calcium gluconate is known for its superior purity and high quality. It also has excellent bioavailability and is hence widely used in various medical applications.
The food grade segment is expected to grow the fastest over the projected period. This is attributed to the rising demand for food-grade calcium gluconate products and services, which is a major driver for the growth of the calcium gluconate market. Factors like population growth, urbanization, and evolving consumer preferences can contribute to this demand. Continuous technological innovations also play a key role in improving the efficiency and effectiveness of these products and services.
The powder segment dominated the calcium gluconate market. Powdered calcium gluconate is easily used in different foods and cool drinks to improve and fortify its nutritional calcium content.
The liquid is the fastest-growing segment during the forecast period. The ease of use and quick absorption of liquid calcium gluconate make it a preferred choice, especially in emergency medical situations where calcium needs to be administered promptly. Its ability to dissolve easily and be flexible in its application allows it to be used in various industries, including food and beverage, pharmaceuticals, and agriculture.
The calcium supplement segment held the largest share of the calcium gluconate market in 2023 and is also anticipated to grow at the fastest rate during the studied period. Calcium gluconate is widely utilized as a calcium supplement to combat calcium deficiencies and promote bone health. This makes it a sought-after choice, particularly among individuals such as pregnant women, the elderly, and those with specific medical conditions who require daily calcium supplementation. Moreover, the market for calcium gluconate tablets is expected to grow in the coming years due to increasing demand for nutraceuticals and dietary supplements.
The food & beverages manufacturers segment dominated the calcium glucose market share in 2023 and is expected to grow significantly till 2033. This is because calcium gluconate is commonly added to food and drinks as a mineral supplement and ingredient. It acts as a preservative for various food items like baked goods, dairy products, and canned fruits and vegetables. The increasing awareness of calcium deficiency and the health benefits of consuming calcium-fortified products are driving the demand for calcium gluconate in the food and beverage industry.
Segments Covered in the Report
By Grade
By Form
By Function
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Calcium Gluconate Market
5.1. COVID-19 Landscape: Calcium Gluconate Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Calcium Gluconate Market, By Grade
8.1. Calcium Gluconate Market Revenue and Volume Forecast, by Grade, 2024-2033
8.1.1. Pharmaceutical Grade
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Food Grade
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Calcium Gluconate Market, By Form
9.1. Calcium Gluconate Market Revenue and Volume Forecast, by Form, 2024-2033
9.1.1. Liquid
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Tablet
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powder
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Gel
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Calcium Gluconate Market, By Function
10.1. Calcium Gluconate Market Revenue and Volume Forecast, by Function, 2024-2033
10.1.1. Calcium Supplement
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Bone Health
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Antacid
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Skincare and Cosmetics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Calcium Gluconate Market, By Application
11.1. Calcium Gluconate Market Revenue and Volume Forecast, by Application, 2024-2033
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Food & Beverages
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Nutraceuticals
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Calcium Gluconate Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Grade (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Function (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)
Chapter 13. Company Profiles
13.1. Pfizer
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Novartis
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Amphastar
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Akorn
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. West-Ward Pharmaceuticals
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Fresenius Kabi USA
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Merck
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Mylan Institutional LLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Grifols USA LLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Baxter International
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client